🚀

오늘의 열정을 계속 이어가세요!

체험은 만족하셨나요? 지식 자료를 소장하고 멋진 의료인으로 성장하세요!

구경하기
Rho(D) Immune Globulin | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

제안하기
닫기
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Rho(D) Immune Globulin

NCLEX Review Guide: Rh(D) Immune Globulin (RhoGAM, WinRho)

Medication Overview

Definition and Purpose

  • Rh(D) Immune Globulin is a blood product that contains antibodies to the Rh(D) antigen found on red blood cells. It is administered to Rh-negative mothers who are exposed to Rh-positive blood to prevent sensitization and subsequent hemolytic disease of the newborn (HDN) in future pregnancies.
  • The medication works by binding to any Rh-positive fetal red blood cells that have entered the maternal circulation, preventing the mother's immune system from recognizing these cells as foreign and developing antibodies against them.

Key Points

  • RhoGAM is preventative, not therapeutic - it cannot reverse sensitization that has already occurred.
  • Administered to Rh-negative mothers only when exposed to Rh-positive blood.

Indications for Administration

  • Administered at approximately 28 weeks gestation to all unsensitized Rh-negative women.
  • Given within 72 hours after delivery of an Rh-positive infant to an Rh-negative mother.
  • Following events that may cause fetal-maternal hemorrhage: amniocentesis, chorionic villus sampling, abortion, ectopic pregnancy, abdominal trauma, placental abruption, or external cephalic version.

Key Points

  • The 72-hour window after delivery or potential exposure is critical for effectiveness.
  • Can still be administered up to 10 days post-exposure, but efficacy may be reduced.

Pharmacological Considerations

Dosage and Administration

  • Antenatal prophylaxis: Standard dose of 300 mcg (or 1 vial) IM at 28 weeks gestation.
  • Postpartum: 300 mcg IM within 72 hours of delivery if infant is Rh-positive.
  • For first-trimester events (abortion, ectopic pregnancy): Microdose of 50 mcg IM is typically sufficient.

    Administration Procedure

  1. Verify patient's Rh status and absence of Rh antibodies.
  2. Confirm the correct dose based on gestational age and type of exposure.
  3. Administer via intramuscular injection, preferably in the deltoid muscle.
  4. Document administration in the patient's record.
  5. Monitor for adverse reactions for at least 20 minutes after administration.

Key Points

  • RhoGAM is administered intramuscularly only, never intravenously.
  • Dosage varies based on the type of exposure and gestational age.

Contraindications and Precautions

  • Contraindicated in Rh-positive individuals and those already sensitized to the Rh factor.
  • Use with caution in patients with known hypersensitivity to immunoglobulins or thimerosal (present in some formulations).
  • Contains trace amounts of IgA; patients with IgA deficiency may be at risk for anaphylaxis.

Always verify maternal blood type and antibody screen before administration. RhoGAM should NOT be given to women who are already sensitized (have anti-D antibodies) as it will not be effective and wastes a valuable blood product.

Key Points

  • Prior to administration, verify negative antibody screen to confirm the mother is not already sensitized.
  • RhoGAM is a blood product and should be treated with appropriate precautions.

Clinical Applications

Mechanism of Action

  • Passive immunization: RhoGAM provides pre-formed antibodies that coat any Rh-positive fetal red blood cells in the maternal circulation, masking them from the mother's immune system.
  • By preventing recognition of these foreign cells, the mother's immune system does not mount a response or create antibodies against the Rh factor.
  • This prevents sensitization, which could lead to hemolytic disease of the newborn in subsequent pregnancies with Rh-positive fetuses.

Memory Aid

"RhoGAM BLOCKS the CLOCK" - It blocks the mother's immune response before the clock runs out (72 hours) to prevent future problems.

Key Points

  • RhoGAM prevents sensitization but cannot reverse it once it has occurred.
  • The antibodies in RhoGAM have a half-life of approximately 24 days, providing protection for about 12 weeks.

Clinical Scenario

A 26-year-old Rh-negative woman (G2P1) at 28 weeks gestation presents for routine prenatal care. Her antibody screen is negative. Her previous child was Rh-positive, and she received RhoGAM after delivery.

Appropriate Nursing Action: Administer the scheduled antenatal dose of RhoGAM (300 mcg IM) at this visit. Educate the patient about the importance of returning for postpartum RhoGAM if her baby is Rh-positive.

Adverse Effects and Nursing Considerations

  • Common side effects include injection site pain, low-grade fever, mild headache, and myalgia.
  • Rare but serious adverse effects include anaphylaxis, hemolysis (particularly in patients with immune thrombocytopenia), and systemic reactions.
  • Nursing responsibilities include patient education about the purpose of RhoGAM, verifying the correct patient and medication, and monitoring for adverse reactions.

Key Points

  • Monitor for allergic reactions for at least 20 minutes after administration.
  • Maintain emergency equipment and medications nearby in case of anaphylaxis.

Summary of Key Points

  • RhoGAM prevents Rh sensitization in Rh-negative mothers exposed to Rh-positive blood, protecting future pregnancies from hemolytic disease of the newborn.
  • Standard dosing includes 300 mcg IM at 28 weeks gestation and within 72 hours after delivery of an Rh-positive infant.
  • RhoGAM is administered only to Rh-negative, unsensitized mothers; it cannot reverse existing sensitization.
  • The medication must be given within 72 hours of potential exposure to be most effective, though it may provide some protection up to 10 days post-exposure.
  • As a blood product, RhoGAM carries risks of allergic reactions and should be administered with appropriate precautions.

Self-Assessment Checklist

  • I understand which patients should receive RhoGAM
  • I know the correct timing for RhoGAM administration
  • I can explain the mechanism of action to patients
  • I understand the nursing considerations for administration
  • I can identify situations requiring RhoGAM beyond routine antenatal and postpartum care

Commonly Confused Points

RhoGAM vs. Other Immune Globulins

Feature Rh(D) Immune Globulin (RhoGAM) IVIG (Intravenous Immune Globulin)
Primary Use Prevention of Rh sensitization Treatment of immune disorders, autoimmune conditions
Administration Intramuscular only Intravenous
Target Population Rh-negative unsensitized women Various patient populations with immune deficiencies
Antibody Specificity Specific to Rh(D) antigen Contains pooled antibodies against multiple antigens

Common Misconceptions

  • Misconception: RhoGAM is needed for all pregnant women.
    Correction: Only Rh-negative women potentially exposed to Rh-positive blood need RhoGAM.
  • Misconception: RhoGAM can treat existing sensitization.
    Correction: RhoGAM is preventive only and cannot reverse sensitization that has already occurred.
  • Misconception: RhoGAM is only needed after delivery.
    Correction: RhoGAM is given both antenatally at 28 weeks and after delivery, plus after events that may cause fetal-maternal hemorrhage.

Common Pitfalls

  • Not verifying Rh status and antibody screen before administration
  • Missing the 72-hour window for administration after potential exposure
  • Failing to administer RhoGAM after early pregnancy loss or procedures

Study Tips

Memory Aids

RhoGAM Administration Timeline

"28-72-10": 28 weeks gestation for antenatal dose, 72 hours post-exposure for optimal effectiveness, up to 10 days post-exposure with reduced efficacy.

Who Needs RhoGAM?

"Negative Mom, Positive Baby" - Remember that RhoGAM is for Rh-negative mothers carrying or delivering Rh-positive babies.

Indications for RhoGAM

"ABCDE" for RhoGAM indications:
A - Amniocentesis/Abortion
B - Birth of Rh+ baby
C - CVS (Chorionic Villus Sampling)
D - Delivery at 28 weeks (antenatal prophylaxis)
E - External cephalic version/Ectopic pregnancy

Quick Knowledge Check

1. When should the antenatal dose of RhoGAM be administered?

2. What is the window of time for administering RhoGAM after delivery?

3. Can RhoGAM reverse sensitization that has already occurred?

4. What is the standard dose of RhoGAM for postpartum prophylaxis?

5. Should RhoGAM be administered to an Rh-positive mother with an Rh-negative baby?

Answers

  1. 28 weeks gestation
  2. Within 72 hours (optimally); may be given up to 10 days with reduced efficacy
  3. No, it can only prevent sensitization, not reverse it
  4. 300 mcg IM
  5. No, RhoGAM is only for Rh-negative mothers

Remember: Understanding RhoGAM administration is crucial for preventing hemolytic disease of the newborn in future pregnancies. This medication has dramatically reduced the incidence of Rh sensitization and saved countless newborn lives. Your knowledge of this important preventive therapy directly impacts maternal and fetal outcomes!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.